Schonfeld Strategic Advisors’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-35,300
| Closed | -$108K | – | 2284 |
|
|
2024
Q4 | $108K | Sell |
35,300
-82,600
| -70% | -$252K | ﹤0.01% | 1769 |
|
|
2024
Q3 | $301K | Sell |
117,900
-216,207
| -65% | -$551K | ﹤0.01% | 1510 |
|
|
2024
Q2 | $1.09M | Buy |
334,107
+287,503
| +617% | +$937K | 0.01% | 1048 |
|
|
2024
Q1 | $247K | Buy |
46,604
+26,545
| +132% | +$141K | ﹤0.01% | 1538 |
|
|
2023
Q4 | $86.9K | Buy |
+20,059
| New | +$86.9K | ﹤0.01% | 1546 |
|
|
2020
Q2 | – | Sell |
-17,582
| Closed | -$148K | – | 1439 |
|
|
2020
Q1 | $148K | Sell |
17,582
-61,106
| -78% | -$514K | 0.01% | 961 |
|
|
2019
Q4 | $689K | Buy |
+78,688
| New | +$689K | 0.02% | 623 |
|
|
2019
Q3 | – | Sell |
-14,200
| Closed | -$180K | – | 1164 |
|
|
2019
Q2 | $180K | Buy |
14,200
+4,200
| +42% | +$53.2K | 0.01% | 901 |
|
|
2019
Q1 | $388K | Sell |
10,000
-30,654
| -75% | -$1.19M | 0.01% | 769 |
|
|
2018
Q4 | $827K | Buy |
40,654
+35,354
| +667% | +$719K | 0.03% | 523 |
|
|
2018
Q3 | $243K | Buy |
5,300
+1,800
| +51% | +$82.5K | 0.01% | 723 |
|
|
2018
Q2 | $207K | Buy |
+3,500
| New | +$207K | 0.01% | 697 |
|
|
2017
Q4 | – | Sell |
-16,365
| Closed | -$1.96M | – | 821 |
|
|
2017
Q3 | $1.96M | Buy |
16,365
+13,065
| +396% | +$1.56M | 0.18% | 159 |
|
|
2017
Q2 | $288K | Buy |
+3,300
| New | +$288K | 0.03% | 487 |
|
|
2016
Q4 | – | Sell |
-18,596
| Closed | -$1.25M | – | 631 |
|
|
2016
Q3 | $1.25M | Buy |
+18,596
| New | +$1.25M | 0.21% | 137 |
|